(1)
Persistent Supravenous Erythematous Eruption (PSEE): A Scoping Review on an Adverse Effect Related to Docetaxel Infusion. RSD 2022, 11 (5), e21111527974. https://doi.org/10.33448/rsd-v11i5.27974.